Model and validation accuracy
| Model errorrate (%) | Validation sensitivity (%) | Validation specificity (%) | p Value | |
|---|---|---|---|---|
| COPD, chronic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis; NSCCA, non-small cell carcinoma; PAH, pulmonary arterial hypertension. | ||||
| The models were built from a random selection of 70% of the study subjects and validated with the remaining 30%. | ||||
| NSCCA | 14.1 | 73.3 | 72.4 | 0.01 |
| Healthy | 6.7 | 57.1 | 78.4 | 0.23 |
| Sarcoidosis | 10.0 | 16.7 | 81.1 | 0.69 |
| PAH | 13.3 | 16.7 | 73 | 0.51 |
| IPF | 9.8 | 40.0 | 92.3 | 0.09 |
| COPD | 17.3 | 33.3 | 78.9 | 0.41 |